SHINE making progress

Print Print
Jim Leute
Thursday, June 6, 2013

— The company that plans to build a production plant in Janesville continues to make progress in its bid to produce a medical isotope used in more than 40 million medical imaging tests each year.

SHINE Medical Technologies is working toward regulatory approval of a $85 million production plant that will use low-enriched uranium in a series of eight accelerators to produce molybdenum-99, a medical isotope used in more than 30 kinds of diagnostic imaging procedures performed more than 50,000 times each day in the United States.

The company said Tuesday it has completed its construction permit application to the Nuclear Regulatory Commission.

In March, SHINE submitted environmental, general and financial information to the federal commission. Its most recent filing included a preliminary design and additional safety analyses, as required by federal regulations.

The filing of the permit begins the commission's process of formal acceptance and review, which is expected to stretch into fall 2014.

"The completion of our construction permit application and submission to NRC is a significant milestone for SHINE's plans to construct and operate a facility to produce medical isotopes in Janesville," said Greg Piefer, the company's chief executive officer and founder.

"Our team worked hard to complete the filing, and it represents an important step forward for building and operating a facility that will address an important worldwide health care issue."

SHINE officials believe the Janesville plant will produce enough Mo-99 to meet half of the U.S. demand by 2016.

Company officials will be in Janesville next week to present an update on their progress.

The information session is one in a series of opportunities for SHINE to share information with and respond to questions from the community, Piefer said.

"Since our last meeting, the company has made great progress on many fronts, including the submission of the construction application to the Nuclear Regulatory Commission," he said, adding the session is part of SHINE's commitment to Janesville and will help keep the community informed on the progress toward building the manufacturing facility on the city's south side.

If you go

Officials from SHINE Medical Technologies will hold an information session from 4:30-5:30 p.m. Thursday, June 13, at the Holiday Inn Express, 3100 Wellington Place, Janesville.

Anyone interested in learning more about SHINE, its products or the facility planned for Janesville is welcome to attend. There will be an opportunity at the end of the presentation for questions and answers.

Last updated: 7:56 am Monday, July 29, 2013

Print Print